D. Shepherd

Risk Factors for Prostate Cancer

D. Shepherd, 2001 .

Inhibition of Growth and Metastasis of Orthotopic Human Prostate Cancer in Athymic Mice by Combination Therapy with Pegylated Interferon-- 2 b and Docetaxel

C. Bucana, C. Dinney, I. Fidler, 2002 .

Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

C. Bucana, C. Dinney, I. Fidler, 2002, Cancer research.

Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.

I. Fidler, C. Logothetis, T. Karashima, 2003, Journal of the National Cancer Institute.

Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy.

P. Humphrey, Deborah S. Smith, D. Stahl, 1996, The Journal of urology.

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population.

P. Humphrey, W. Catalona, Deborah S. Smith, 1998, Urology.

Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

I. Fidler, T. Karashima, H. Uehara, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening.

P. Humphrey, W. Catalona, Deborah S. Smith, 1996, The Journal of urology.

Risk Factors for Prostate Cancer

D. Shepherd, 2001 .